CXCL13-producing CD4+ Th cells have been reported in patients with breast cancer, in whom they were enriched in tertiary lymphoid structures, and their presence correlated with B cell infiltration and GC maturation at the tumor site and was associated with improved prognosis (28, 29). Here, CXCL13 is linked to neoplasm.